68Ga-DOTA-G-02113

N/A

Report date: 2025/01/26 16:56:14

Base Information

Drug Name68Ga-DOTA-G-02113
Drug Alias NameGallium-68-DOTA-G-02113DOTA-G-02113-[68Ga]
ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor 2 agonistsSomatostatin receptor 5 agonists
TargetsSomatostatin receptor 5Somatostatin receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSomtherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSomtherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A